Geode Capital Management
IDYA icon

Geode Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Geode Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.4M Sell
2,425,602
-75,122
-3% -$2.3M ﹤0.01% 1274
2026
Q1 		$83.3M Buy
2,500,724
+427,141
+21% +$14.3M 0.01% 1206
2025
Q4 		$71.7M Sell
2,073,583
-76,450
-4% -$2.44M ﹤0.01% 1279
2025
Q3 		$58.5M Buy
2,150,033
+36,869
+2% +$892K ﹤0.01% 1382
2025
Q2 		$44.4M Buy
2,113,164
+33,286
+2% +$639K ﹤0.01% 1491
2025
Q1 		$34.1M Buy
2,079,878
+91,197
+5% +$1.94M ﹤0.01% 1598
2024
Q4 		$51.1M Buy
1,988,681
+43,226
+2% +$1.22M ﹤0.01% 1420
2024
Q3 		$61.6M Buy
1,945,455
+172,838
+10% +$6.55M 0.01% 1300
2024
Q2 		$62.2M Buy
1,772,617
+206,902
+13% +$8.19M 0.01% 1205
2024
Q1 		$68.7M Buy
1,565,715
+214,378
+16% +$9.22M 0.01% 1155
2023
Q4 		$48.1M Buy
1,351,337
+190,232
+16% +$5.68M 0.01% 1360
2023
Q3 		$31.3M Buy
1,161,105
+138,352
+14% +$3.51M ﹤0.01% 1533
2023
Q2 		$24M Buy
1,022,753
+162,819
+19% +$3.35M ﹤0.01% 1727
2023
Q1 		$11.8M Buy
859,934
+54,033
+7% +$900K ﹤0.01% 2146
2022
Q4 		$14.6M Buy
805,901
+179,046
+29% +$3.01M ﹤0.01% 1990
2022
Q3 		$9.35M Buy
626,855
+7,687
+1% +$99.8K ﹤0.01% 2311
2022
Q2 		$8.54M Buy
619,168
+4,558
+0.7% +$50.7K ﹤0.01% 2365
2022
Q1 		$6.88M Buy
614,610
+47,100
+8% +$694K ﹤0.01% 2603
2021
Q4 		$13.4M Buy
567,510
+36,743
+7% +$854K ﹤0.01% 2236
2021
Q3 		$13.5M Buy
530,767
+144,879
+38% +$3.38M ﹤0.01% 2244
2021
Q2 		$8.1M Buy
385,888
+107,795
+39% +$2.21M ﹤0.01% 2611
2021
Q1 		$6.54M Buy
278,093
+57,324
+26% +$1.11M ﹤0.01% 2647
2020
Q4 		$3.09M Buy
220,769
+52,130
+31% +$706K ﹤0.01% 2852
2020
Q3 		$2.12M Buy
168,639
+54,383
+48% +$673K ﹤0.01% 2850
2020
Q2 		$1.62M Buy
+114,256
New +$900K ﹤0.01% 2954

Other funds holding IDYA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management's IDYA Position: Q2 2026 in Review

Geode Capital Management reduced its IDEAYA Biosciences (IDYA) stake by 3% in Q2 2026, selling an estimated $2.3M and leaving 2,425,602 shares worth $90.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1274.

Geode Capital Management first reported a position in IDYA in Q2 2020 and has held it in 25 quarters since. 266 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Geode Capital Management held 2,425,602 shares of IDEAYA Biosciences worth $90.4M as of Q2 2026.
  • Geode Capital Management sold 75,122 IDEAYA Biosciences shares in Q2 2026, an estimated $2.3M.
  • IDEAYA Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #1274 holding.
  • Geode Capital Management first reported a position in IDEAYA Biosciences in Q2 2020 and has held it in 25 quarters since.
  • 266 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.